Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 319, pseudogene (RN7SL319P)

Target
RN7SL319P
Molecular classification
Other (pseudogene)
01

Overview

RNA, 7SL, cytoplasmic 319, pseudogene (RN7SL319P) is a human pseudogene related to the 7SL RNA gene. The functional 7SL RNA is a core component of the signal recognition particle (SRP), which is essential for targeting secretory proteins to the endoplasmic reticulum[1][7]. In contrast, most RN7SL pseudogenes—including RN7SL319P—are unexpressed, non-functional genomic elements that arose via retrotransposition or genomic rearrangement, leading to loss of coding potential and biological function[4][5][8]. These pseudogenes do not encode any active protein or RNA product and are not considered therapeutic targets, receptors, enzymes, or druggable entities. There is no evidence implicating RN7SL319P in disease, nor are there any known drugs, biomarkers, or safety issues related to this pseudogene. Key points: - Not a therapeutic target: RN7SL319P lacks protein-coding or functional RNA capacity and does not participate in recognized biological roles or disease processes[5]. - Pseudogene: Classified as a non-functional genomic sequence (pseudogene) related to the parent 7SL RNA gene[5][4]. - No known biological, pathological, or pharmacological function: Pseudogenes like RN7SL319P are generally considered genomic relics with no direct functional impact[5]. Note: - The query describes a *non-functional pseudogene* rather than a valid receptor, enzyme, transporter, or other therapeutic target class. - This makes RN7SL319P inappropriate as a therapeutic target for most scientific or drug discovery purposes. - If information about the functional 7SL RNA (component of the SRP) is required, please specify, as 7SL RNA performs vital roles in protein targeting and cell biology[1][7].

Other names
RN7SL319P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 319, pseudogene (RN7SL319P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 319, pseudogene (RN7SL319P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call